Skip to main content
Erschienen in: Journal of Cancer Education 1/2011

01.03.2011

Understanding the Processes of Patient Navigation to Reduce Disparities in Cancer Care: Perspectives of Trained Navigators from the Field

verfasst von: Pascal Jean-Pierre, Samantha Hendren, Kevin Fiscella, Starlene Loader, Sally Rousseau, Bonnie Schwartzbauer, Mechelle Sanders, Jennifer Carroll, Ronald Epstein

Erschienen in: Journal of Cancer Education | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Patient navigation (PN) programs are being widely implemented to reduce disparities in cancer care for racial/ethnic minorities and the poor. However, few systematic studies cogently describe the processes of PN. We qualitatively analyzed 21 transcripts of semistructured exit interviews with three navigators about their experiences with patients who completed a randomized trial of PN. We iteratively discussed codes/categories, reflective remarks, and ways to focus/organize data and developed rules for summarizing data. We followed a three-stage analysis model: reduction, display, and conclusion drawing/verification. We used ATLAS.ti_5.2 for text segmentation, coding, and retrieval. Four categories of factors affecting cancer care outcomes emerged: patients, navigators, navigation processes, and external factors. These categories formed a preliminary conceptual framework describing ways in which PN processes influenced outcomes. Relationships between processes and outcomes were influenced by patient, navigator, and external factors. The process of PN has at its core relationship-building and instrumental assistance. An enhanced understanding of the process of PN derived from our analyses will facilitate improvement in navigators’ training and rational design of new PN programs to reduce disparities in cancer-related care.
Literatur
1.
Zurück zum Zitat Estachon J, Armour B, Ofili E et al (2001) Racial and ethnic disparities in health care. JAMA 285:883CrossRef Estachon J, Armour B, Ofili E et al (2001) Racial and ethnic disparities in health care. JAMA 285:883CrossRef
2.
Zurück zum Zitat Fiscella K, Franks P, Gold MR et al (2000) Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA 283:2579–2584CrossRefPubMed Fiscella K, Franks P, Gold MR et al (2000) Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA 283:2579–2584CrossRefPubMed
3.
Zurück zum Zitat Institute of Medicine (2002) The future of the public’s health. Washington, D.C. National Academy Press Institute of Medicine (2002) The future of the public’s health. Washington, D.C. National Academy Press
4.
Zurück zum Zitat Smedley BD, Stith AY, Nelson AR (eds) (2003) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment: confronting racial and ethnic disparities in health care appendix C: federal-level and other initiatives to address racial and ethnic disparities in healthcare. (384–391). Washington, DC. National Academies Press Smedley BD, Stith AY, Nelson AR (eds) (2003) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment: confronting racial and ethnic disparities in health care appendix C: federal-level and other initiatives to address racial and ethnic disparities in healthcare. (384–391). Washington, DC. National Academies Press
5.
Zurück zum Zitat Van Ryn M, Burke J (2000) The effect of patient race and socioeconomic status on physicians’ perceptions of patients. Soc Sci Med 50:813–828CrossRefPubMed Van Ryn M, Burke J (2000) The effect of patient race and socioeconomic status on physicians’ perceptions of patients. Soc Sci Med 50:813–828CrossRefPubMed
6.
Zurück zum Zitat Bradley CJ, Given CW, Roberts C (2001) Disparities in cancer diagnosis and survival. Cancer 91(1):178–188CrossRefPubMed Bradley CJ, Given CW, Roberts C (2001) Disparities in cancer diagnosis and survival. Cancer 91(1):178–188CrossRefPubMed
7.
Zurück zum Zitat LaVeist TA (2002) “Segregation, poverty, and empowerment: health consequences of African Americans.” In T A. LaVeist (ed) Race, ethnicity, and health: a public health reader. San Franscisco, Jossey-Bass LaVeist TA (2002) “Segregation, poverty, and empowerment: health consequences of African Americans.” In T A. LaVeist (ed) Race, ethnicity, and health: a public health reader. San Franscisco, Jossey-Bass
8.
Zurück zum Zitat Roetzheim RG, Pal N, Tennant C et al (1999) Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409–1915CrossRefPubMed Roetzheim RG, Pal N, Tennant C et al (1999) Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409–1915CrossRefPubMed
9.
Zurück zum Zitat Gornick ME, Eggers PW, Riley GF (2004) Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. Health Serv Res 39:1403–1428CrossRefPubMed Gornick ME, Eggers PW, Riley GF (2004) Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. Health Serv Res 39:1403–1428CrossRefPubMed
10.
Zurück zum Zitat Griggs JJ, Culakova E, Sorbero ME et al (2007) Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol 25(18):2522–2527CrossRefPubMed Griggs JJ, Culakova E, Sorbero ME et al (2007) Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol 25(18):2522–2527CrossRefPubMed
11.
Zurück zum Zitat Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Nat Cancer Inst 94:334–357PubMed Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Nat Cancer Inst 94:334–357PubMed
12.
Zurück zum Zitat Cooper LA, Hill MN, Powe NR (2002) Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med 17:477–486CrossRefPubMed Cooper LA, Hill MN, Powe NR (2002) Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med 17:477–486CrossRefPubMed
13.
Zurück zum Zitat Battaglia TA, Roloff K, Posner MA et al (2007) Improving follow-up to abnormal breast cancer screening in an urban population: a patient navigation intervention. Cancer Supplement 109(2):359–367 Battaglia TA, Roloff K, Posner MA et al (2007) Improving follow-up to abnormal breast cancer screening in an urban population: a patient navigation intervention. Cancer Supplement 109(2):359–367
14.
Zurück zum Zitat Freeman H (2006) Patient navigation: a community based strategy to reduce cancer disparities. Journal of Urban Health: Bulletin of the New York Academy of Medicine 83(2):139–141 Freeman H (2006) Patient navigation: a community based strategy to reduce cancer disparities. Journal of Urban Health: Bulletin of the New York Academy of Medicine 83(2):139–141
15.
Zurück zum Zitat Vargas RB, Ryan GW, Jackson CA et al (2008) Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer 113(2):426–433CrossRefPubMed Vargas RB, Ryan GW, Jackson CA et al (2008) Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer 113(2):426–433CrossRefPubMed
16.
Zurück zum Zitat Dohan D, Schrag D (2005) Using navigators to improve care of underserved patients: current practices and approaches. Cancer 104(4):848–855CrossRefPubMed Dohan D, Schrag D (2005) Using navigators to improve care of underserved patients: current practices and approaches. Cancer 104(4):848–855CrossRefPubMed
17.
Zurück zum Zitat Freeman HP, Muth BJ, Kerner JF (1995) Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 3:19–30PubMed Freeman HP, Muth BJ, Kerner JF (1995) Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 3:19–30PubMed
18.
Zurück zum Zitat Petereit DG, Molloy K, Reiner ML et al (2008) Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of South Dakota: initial observations and results. Cancer Control 15(3):254–259PubMed Petereit DG, Molloy K, Reiner ML et al (2008) Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of South Dakota: initial observations and results. Cancer Control 15(3):254–259PubMed
19.
Zurück zum Zitat Miles, MB and Huberman, AM. An expanded sourcebook—qualitative data analysis (2/e). Thousand Oaks, CA: SAGE Miles, MB and Huberman, AM. An expanded sourcebook—qualitative data analysis (2/e). Thousand Oaks, CA: SAGE
20.
Zurück zum Zitat Carroll, JK, Humiston, SG, Meldrum, SC, Salamone, CM, Jean-Pierre, P, Epstein, RM, Fiscella, K. Patients’ expectation with navigation for cancer care. Patient Education and Counseling (In Press) Carroll, JK, Humiston, SG, Meldrum, SC, Salamone, CM, Jean-Pierre, P, Epstein, RM, Fiscella, K. Patients’ expectation with navigation for cancer care. Patient Education and Counseling (In Press)
Metadaten
Titel
Understanding the Processes of Patient Navigation to Reduce Disparities in Cancer Care: Perspectives of Trained Navigators from the Field
verfasst von
Pascal Jean-Pierre
Samantha Hendren
Kevin Fiscella
Starlene Loader
Sally Rousseau
Bonnie Schwartzbauer
Mechelle Sanders
Jennifer Carroll
Ronald Epstein
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 1/2011
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-010-0122-x

Weitere Artikel der Ausgabe 1/2011

Journal of Cancer Education 1/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.